تحميل...
Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths
Severe acute respiratory syndrome coronavirus 2 has spread across the globe affecting more than 10 million people as of August 2020. With the pandemic spreading at such an alarming rate, a lot of efforts are in the process of identification of an effective treatment at it’s earliest. Hydroxychloroqu...
محفوظ في:
| الحاوية / القاعدة: | Eur J Rheumatol |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Medical Research and Education Association
2021
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8133889/ https://ncbi.nlm.nih.gov/pubmed/33044166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2020.20174 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|